Log in
Enquire now
BillionToOne

BillionToOne

A diagnostic DNA testing company using quantified biological data.

OverviewStructured DataIssuesContributors

Contents

billiontoone.com
Is a
Company
Company
Organization
Organization

Company attributes

Industry
Genomics
Genomics
0
Healthcare
Healthcare
DNA
DNA
‌
Genetic testing
Digital health
Digital health
Medical diagnostics
Medical diagnostics
...
Location
United States
United States
Menlo Park, California
Menlo Park, California
Palo Alto, California
Palo Alto, California
San Francisco
San Francisco
B2X
B2B
B2B
CEO
Oguzhan Atay
Oguzhan Atay
Founder
‌
Sukrit Silas
0
‌
Dave Tsao
0
Oguzhan Atay
Oguzhan Atay
0
AngelList URL
angel.co/billiontoone
Pitchbook URL
pitchbook.com/profiles...156479-77
Legal Name
BillionToOne, Inc.
Accelerator
Y Combinator
Y Combinator
0
Accelerator Batch
‌
Y Combinator S17 Batch
0
Legal classification
Corporation
Corporation
Date Incorporated
January 2016
Number of Employees (Ranges)
201 – 5000
Email Address
info@billiontoone.com0
Phone Number
+165046025510
Full Address
1455 Adams Drive Suite 1110 Menlo Park, CA 94025 United States
1035 O’Brien Drive Menlo Park, CA 940250
Place of Incorporation
Delaware
Delaware
0
Investors
Civilization Ventures
Civilization Ventures
Pacific 8 Ventures
Pacific 8 Ventures
David Chan
David Chan
Hummingbird Ventures
Hummingbird Ventures
Wei Guo
Wei Guo
Debanjan Mukherjee
Debanjan Mukherjee
0
Norwest Venture Partners
Norwest Venture Partners
Adams Street Partners
Adams Street Partners
...
DUNS Number
080596376
Founded Date
2016
0
Fax Number
+1 (833) 915-01460
Total Funding Amount (USD)
276,020,000
Latest Funding Round Date
December 2022
Competitors
Human Longevity Inc.
Human Longevity Inc.
Cepheid Inc
Cepheid Inc
Lazarus Bioscience
Lazarus Bioscience
Helix
Helix
Lucence
Lucence
Business Model
Commerce
CTO
David Tsao
David Tsao
Key People
David Tsao
David Tsao
Oguzhan Atay
Oguzhan Atay
Latest Funding Type
Series C
Series C
Patents Assigned (Count)
1
Motto/Tagline
We push the boundaries of molecular diagnostics through quantitative technologies.
Wellfound ID
billiontoone
Technologies Used
MailGun
MailGun
Slack
Slack
Zoom
Zoom
Gmail
Gmail
Country
United States
United States

Other attributes

Company Operating Status
Active
Funding Round Investor
500 Global
500 Global
Latest Funding Round Amount (USD)
48,500,000
Y Combinator URL
ycombinator.com/compani...iontoone0

Founded in 2016 by Dave Tsao, Oguzhan Atay, and Sukrit Silas, BillionToOne is a DNA diagnostic company originating from Y Combinator's S17 accelerator batch. It is located in Palo Alto, California, and uses diagnostic DNA testing that quantifies molecular level bodily changes.

COVID-19 Response

BillionToOne received emergency use authorization from the Food and Drug Administration (FDA) in 2020, for its SARS-CoV-2 test that removes the process of Ribo Nucleic Acid (RNA) extraction, a time-consuming step in COVID-19 testing. BillionToOne developed a COVID-19 testing method called the qSanger-COVID-19 assay. It uses different instrument sets and chemicals than other methods that were applied in 2020. BillionToOne partnered with SwiftBiosciences to manufacture the COVID-19 assay kits and began international distribution in May of 2020.

qSanger

qSangerTM technology is a patent-pending test developed by BillionToOne that works to detect viral RNA. It is based on the technology in Sanger sequencing, a DNA testing method that determines the nucleotide sequence in DNA molecules, also known as the "chain termination method."

Timeline

No Timeline data yet.

Funding Rounds

Products

Acquisitions

SBIR/STTR Awards

Patents

Further Resources

Title
Author
Link
Type
Date

BillionToOne Announces Groundbreaking New COVID-19 Test Unlocking One Million Daily Tests

PR Newswire

https://finance.yahoo.com/news/billiontoone-announces-groundbreaking-covid-19-140000160.html

Web

April 7, 2020

BillionToOne Molecular Counting Technology (2019)

Oguzhan Atay

https://vimeo.com/311952506

Web

January 17, 2019

BillionToOne, Inc. and Eluthia Launch UNITYTM Test, the First Non-Invasive Prenatal Test for Cystic Fibrosis, Spinal Muscular Atrophy and Hemoglobinopathies in Germany, Austria, Switzerland and the Netherlands

BillionToOne, Inc

https://www.prnewswire.com/news-releases/billiontoone-inc-and-eluthia-launch-unity-test-the-first-non-invasive-prenatal-test-for-cystic-fibrosis-spinal-muscular-atrophy-and-hemoglobinopathies-in-germany-austria-switzerland-and-the-netherlands-300949545.html

Web

October 31, 2019

BillionToOne, Inc., announced today that it has closed its follow-on Series A+ funding round of $15 million

BillionToOne, Inc

https://www.prnewswire.com/news-releases/billiontoone-inc-announced-today-that-it-has-closed-its-follow-on-series-a-funding-round-of-15-million-301020957.html

Web

March 10, 2020

Diagnostics firm claims to have potential for 1 million COVID-19 tests per day

https://www.med-technews.com/news/diagnostics-firm-hopes-to-have-unlocked-1-million-covid-19-t/

Web

April 15, 2020

References

Find more companies like BillionToOne

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.